NASDAQ:CRSP

CRISPR Therapeutics Insider Trades

$79.90

+1.92 (+2.46%)

(As of 11/30/2021 04:00 PM ET)

Add

Compare

Today's Range: $76.81
▼
$80.50
50-Day Range: $77.98
▼
$121.25
52-Week Range: $76.71
▼
$220.20

Volume: 1.47 million shs
Average Volume: 1.61 million shs
Market Capitalization: $6.11 billion

P/E Ratio: 16.79
Dividend Yield: N/A
Beta: 2.09

Current
Insider Ownership
Percentage
10.70%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
8

Amount Of
Insider Selling
(Last 12 Months)
$90.89 M

Insider Buying and Selling by Quarter

Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRISPR Therapeutics (NASDAQ CRSP) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/6/2021	Michael John Tomsicek	CFO	Sell	25,000	$138.52	$3,463,000.00	26,891
8/4/2021	Samarth Kulkarni	CEO	Sell	1,500	$125.02	$187,530.00	189,219
7/19/2021	Bradley J Phd Bolzon	Director	Sell	10,000	$126.43	$1,264,300.00
6/30/2021	Rodger Novak	President	Sell	25,000	$165.00	$4,125,000.00	573,007
6/28/2021	Bradley J. Phd Bolzon	Director	Sell	20,375	$152.48	$3,106,780.00	17,159
6/21/2021	Rodger Novak	President	Sell	25,000	$128.62	$3,215,500.00	646,836
6/15/2021	Samarth Kulkarni	CEO	Sell	30,000	$126.43	$3,792,900.00	217,719
6/11/2021	Bradley J Phd Bolzon	Director	Sell	10,000	$126.61	$1,266,100.00	24,948
3/22/2021	Bradley J Phd Bolzon	Director	Sell	30,374	$132.37	$4,020,606.38	57,149
1/19/2021	James R. Kasinger	General Counsel	Sell	27,500	$204.94	$5,635,850.00

1/15/2021	Lawrence Otto Klein	COO	Sell	25,000	$215.20	$5,380,000.00	28,666
1/15/2021	Samarth Kulkarni	CEO	Sell	20,000	$213.67	$4,273,400.00	202,989
12/21/2020	Tony W. Ho	VP	Sell	23,551	$149.23	$3,514,515.73
12/16/2020	Bradley J Phd Bolzon	Director	Sell	7,648	$148.95	$1,139,169.60	6,734
12/10/2020	Bradley J Phd Bolzon	Director	Sell	33,000	$143.35	$4,730,550.00	40,648
12/10/2020	Samarth Kulkarni	CEO	Sell	20,000	$142.29	$2,845,800.00	189,189
12/7/2020	Bradley J Phd Bolzon	Director	Sell	171,004	$154.53	$26,425,248.12	40,648
11/30/2020	Rodger Novak	President	Sell	100,000	$125.00	$12,500,000.00	698,007
9/18/2020	Bradley J Phd Bolzon	Director	Sell	3,035	$86.87	$263,650.45	7,391
9/16/2020	Bradley J Phd Bolzon	Director	Sell	8,965	$86.98	$779,775.70	7,391
9/14/2020	Bradley J Phd Bolzon	Director	Sell	1,155	$84.89	$98,047.95	7,391
9/10/2020	Bradley J Phd Bolzon	Director	Sell	22,845	$85.36	$1,950,049.20	7,391
9/1/2020	Bradley J Phd Bolzon	Director	Sell	60,000	$92.51	$5,550,600.00
9/1/2020	Michael John Tomsicek	CFO	Sell	12,000	$92.26	$1,107,120.00	12,410
9/1/2020	Rodger Novak	President	Sell	25,000	$92.62	$2,315,500.00	651,940
7/7/2020	Rodger Novak	President	Sell	25,000	$90.00	$2,250,000.00	653,593
7/6/2020	Bradley J Phd Bolzon	Director	Sell	20,000	$82.39	$1,647,800.00
6/24/2020	Lawrence Otto Klein	COO	Sell	65,088	$75.93	$4,942,131.84	58,666
6/23/2020	Bradley J Phd Bolzon	Director	Sell	20,000	$73.93	$1,478,600.00
6/23/2020	Rodger Novak	President	Sell	50,000	$75.00	$3,750,000.00	698,007
6/23/2020	Tony W Ho	VP	Sell	7,158	$75.04	$537,136.32	40,676
6/1/2020	Samarth Kulkarni	CEO	Sell	17,275	$64.68	$1,117,347.00	188,801
5/20/2020	Samarth Kulkarni	CEO	Sell	10,693	$65.28	$698,039.04	175,833
5/19/2020	Rodger Novak	President	Sell	50,000	$65.00	$3,250,000.00	798,007
5/11/2020	Lawrence Otto Klein	COO	Sell	25,000	$60.40	$1,510,000.00	45,000
11/19/2019	Pablo J Cagnoni	Director	Sell	7,500	$62.00	$465,000.00	7,500
11/19/2019	Rodger Novak	President	Sell	33,618	$70.00	$2,353,260.00	33,618
11/12/2019	Pablo J Cagnoni	Director	Sell	7,500	$55.00	$412,500.00	7,500
10/30/2019	Pablo J Cagnoni	Director	Sell	7,500	$52.00	$390,000.00	7,500
7/11/2019	Lawrence Otto Klein	Insider	Sell	20,000	$50.02	$1,000,400.00	31,579
7/10/2019	Rodger Novak	President	Sell	50,000	$50.00	$2,500,000.00	848,007
6/17/2019	Samarth Kulkarni	CEO	Sell	20,000	$46.00	$920,000.00	185,801
6/10/2019	Rodger Novak	President	Sell	50,000	$45.00	$2,250,000.00	898,007
4/29/2019	Samarth Kulkarni	CEO	Sell	20,000	$42.03	$840,600.00	186,542
3/4/2019	Rodger Novak	President	Sell	85,220	$40.40	$3,442,888.00	1,024,534
3/1/2019	Rodger Novak	President	Sell	8,693	$40.01	$347,806.93	1,024,534
2/25/2019	Rodger Novak	President	Sell	14,780	$40.00	$591,200.00	1,033,227
1/8/2019	Rodger Novak	President	Sell	17,310	$35.09	$607,407.90	1,130,697
12/27/2018	Vertex Pharmaceuticals (Europe	Major Shareholder	Buy	40,198	$24.93	$1,002,136.14
12/24/2018	Vertex Pharmaceuticals (Europe	Major Shareholder	Buy	90,742	$24.08	$2,185,067.36
12/21/2018	Vertex Pharmaceuticals (Europe	Major Shareholder	Buy	22,742	$22.58	$513,514.36
12/18/2018	Kurt Von Emster	Director	Sell	72,934	$29.85	$2,177,079.90
7/5/2018	Pablo J Cagnoni	Director	Sell	7,500	$62.00	$465,000.00	5,816
7/3/2018	Pablo J Cagnoni	Director	Sell	5,816	$62.00	$360,592.00	5,816
6/5/2018	Kurt Von Emster	Director	Sell	920	$12.51	$11,509.20	90,000
6/1/2018	Samarth Kulkarni	CEO	Sell	15,000	$69.36	$1,040,400.00	163,560
5/17/2018	Rodger Novak	President	Sell	75,000	$60.00	$4,500,000.00	1,183,247
5/14/2018	Kurt Von Emster	Director	Sell	650,000	$54.39	$35,353,500.00	5,629
5/11/2018	Kurt Von Emster	Director	Sell	250,000	$52.84	$13,210,000.00
5/8/2018	Bradley J Phd Bolzon	Director	Sell	128,950	$50.39	$6,497,790.50	37,645
4/30/2018	Bradley J Phd Bolzon	Director	Sell	30,566	$50.29	$1,537,164.14	43,986
4/27/2018	Thomas Woiwode	Director	Sell	222,258	$50.11	$11,137,348.38
4/24/2018	Versant Venture Capital V, L.P	Major Shareholder	Sell	22,841	$50.99	$1,164,662.59
4/23/2018	Bradley J Phd Bolzon	Director	Sell	101,994	$50.68	$5,169,055.92	43,986
1/16/2018	Tyler Dylan-Hyde	Insider	Sell	66,000	$28.03	$1,849,980.00	25,204
1/5/2018	Aktiengesellschaft Bayer	Major Shareholder	Buy	527,472	$22.75	$11,999,988.00
1/5/2018	Kurt Von Emster	Director	Sell	92,337	$26.96	$2,489,405.52
1/2/2018	Kurt Von Emster	Director	Sell	37,754	$26.76	$1,010,297.04
1/2/2018	Tyler Dylan-Hyde	Insider	Sell	38,000	$21.64	$822,320.00	70,204
12/29/2017	Tyler Dylan-Hyde	Insider	Sell	31,000	$22.72	$704,320.00
12/28/2017	Tyler Dylan-Hyde	Insider	Sell	700	$21.75	$15,225.00	115,904
12/22/2017	Thomas Woiwode	Director	Sell	3,059	$20.29	$62,067.11	4,959
12/22/2017	Tyler Dylan-Hyde	Insider	Sell	15,000	$20.55	$308,250.00	115,204
12/15/2017	Tyler Dylan-Hyde	Insider	Sell	15,000	$18.90	$283,500.00	130,204
12/4/2017	Corp /De/ Celgene	Major Shareholder	Sell	1,112,446	$18.98	$21,114,225.08
12/1/2017	Corp /De/ Celgene	Major Shareholder	Sell	87,991	$19.10	$1,680,628.10
11/29/2017	Corp /De/ Celgene	Major Shareholder	Sell	4,263	$19.25	$82,062.75
11/27/2017	Corp /De/ Celgene	Major Shareholder	Sell	27,990	$19.75	$552,802.50
11/27/2017	Thomas Woiwode	Director	Sell	200	$20.24	$4,048.00	8,218
11/24/2017	Corp /De/ Celgene	Major Shareholder	Sell	26,010	$20.00	$520,200.00
11/24/2017	Thomas Woiwode	Director	Sell	1,700	$20.21	$34,357.00	8,218
11/22/2017	Corp /De/ Celgene	Major Shareholder	Sell	256,000	$19.76	$5,058,560.00
11/20/2017	Corp /De/ Celgene	Major Shareholder	Sell	158,718	$19.02	$3,018,816.36
11/17/2017	Corp /De/ Celgene	Major Shareholder	Sell	51,282	$18.44	$945,640.08
11/15/2017	Corp /De/ Celgene	Major Shareholder	Sell	15,000	$17.67	$265,050.00
11/13/2017	Corp /De/ Celgene	Major Shareholder	Sell	65,093	$17.76	$1,156,051.68
11/10/2017	Corp /De/ Celgene	Major Shareholder	Sell	10,000	$17.28	$172,800.00
11/8/2017	Corp /De/ Celgene	Major Shareholder	Sell	16,875	$18.06	$304,762.50
11/6/2017	Corp /De/ Celgene	Major Shareholder	Sell	79,327	$18.89	$1,498,487.03
11/3/2017	Corp /De/ Celgene	Major Shareholder	Sell	22,759	$19.10	$434,696.90
9/5/2017	Rodger Novak	CEO	Sell	18,470	$20.76	$383,437.20	1,148,007
8/30/2017	Rodger Novak	CEO	Sell	75,795	$20.25	$1,534,848.75	1,232,697
8/30/2017	Samarth Kulkarni	Insider	Sell	27,154	$20.08	$545,252.32	110,893
8/28/2017	Kurt Von Emster	Director	Sell	88,011	$19.79	$1,741,737.69
8/25/2017	Kurt Von Emster	Director	Sell	22,781	$19.42	$442,407.02
8/23/2017	Kurt Von Emster	Director	Sell	17,989	$18.53	$333,336.17
8/21/2017	Kurt Von Emster	Director	Sell	3,150	$18.52	$58,338.00
8/17/2017	Kurt Von Emster	Director	Sell	34,141	$19.06	$650,727.46
8/15/2017	Kurt Von Emster	Director	Sell	55,569	$19.59	$1,088,596.71
8/8/2017	Kurt Von Emster	Director	Sell	35,473	$18.63	$660,861.99
8/8/2017	Tyler Dylan-Hyde	Insider	Sell	15,000	$18.57	$278,550.00	167,727
8/4/2017	Kurt Von Emster	Director	Sell	50,477	$17.81	$898,995.37
8/1/2017	Kurt Von Emster	Director	Sell	5,512	$17.51	$96,515.12
7/28/2017	Kurt Von Emster	Director	Sell	41,312	$17.63	$728,330.56
7/26/2017	Kurt Von Emster	Director	Sell	32,930	$17.60	$579,568.00
7/14/2017	Kurt Von Emster	Director	Sell	69,859	$16.84	$1,176,425.56
7/12/2017	Kurt Von Emster	Director	Sell	31,992	$16.56	$529,787.52
7/5/2017	Kurt Von Emster	Director	Sell	4,254	$16.26	$69,170.04
6/29/2017	Kurt Von Emster	Director	Sell	43,202	$16.90	$730,113.80
6/27/2017	Kurt Von Emster	Director	Sell	81,435	$17.08	$1,390,909.80
6/23/2017	Kurt Von Emster	Director	Sell	32,368	$16.23	$525,332.64
6/22/2017	Rodger Novak	CEO	Sell	10,825	$15.37	$166,380.25	1,225,830
6/21/2017	Rodger Novak	CEO	Sell	30,222	$15.01	$453,632.22	1,230,397
6/9/2017	Rodger Novak	CEO	Sell	5,303	$15.02	$79,651.06	1,219,208
5/30/2017	Rodger Novak	CEO	Sell	3,650	$15.02	$54,823.00	1,218,655
5/17/2017	Rodger Novak	CEO	Sell	50,000	$16.26	$813,000.00	1,239,082
5/5/2017	Rodger Novak	CEO	Sell	616	$16.92	$10,422.72	1,215,621
5/4/2017	Rodger Novak	CEO	Sell	49,384	$16.30	$804,959.20	1,230,929
4/28/2017	Tyler Dylan-Hyde	Insider	Sell	21,639	$16.78	$363,102.42	180,495
4/27/2017	Samarth Kulkarni	Insider	Sell	5,481	$16.76	$91,861.56	137,322
4/25/2017	Samarth Kulkarni	Insider	Sell	11,615	$16.78	$194,899.70	137,047
4/20/2017	Rodger Novak	CEO	Sell	50,000	$17.88	$894,000.00	1,262,711
4/20/2017	Tyler Dylan-Hyde	Insider	Sell	10,177	$17.71	$180,234.67	200,274
10/24/2016	Corp /De/ Celgene	Major Shareholder	Buy	800,150	$14.00	$11,202,100.00
10/24/2016	Simeon George	Director	Buy	66,500	$14.00	$931,000.00

(Data available from 1/1/2013 forward)

CRISPR Therapeutics (NASDAQ:CRSP) Insider Trade Frequently Asked Questions

Who is on CRISPR Therapeutics's Insider Roster?: The list of insiders at CRISPR Therapeutics includes Bradley J Phd Bolzon, James R. Kasinger, Kurt Von Emster, Lawrence Otto Klein, Michael John Tomsicek, Pablo J Cagnoni, Rodger Novak, Samarth Kulkarni, Tony W Ho, and Vertex Pharmaceuticals (Europe.Learn more on CRSP's insiders
What percentage of CRISPR Therapeutics stock is owned by insiders?: 10.70% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings

Which CRISPR Therapeutics insiders have been selling company stock?: The following insiders have sold CRISPR Therapeutics stock in the last 24 months: Bradley J Phd Bolzon ($50,614,497.40), James R. Kasinger ($5,635,850.00), Lawrence Otto Klein ($11,832,131.84), Michael John Tomsicek ($4,570,120.00), Rodger Novak ($31,406,000.00), Samarth Kulkarni ($12,915,016.04), and Tony W Ho ($537,136.32).
How much insider selling is happening at CRISPR Therapeutics?: Insiders have sold a total of 1,028,166 CRISPR Therapeutics shares in the last 24 months for a total of $124,132,047.33 sold.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

CRISPR Therapeutics Insider Trades

Current
Insider Ownership
Percentage
10.70%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
8

Amount Of
Insider Selling
(Last 12 Months)
$90.89 M

Insider Buying and Selling by Quarter

CRISPR Therapeutics (NASDAQ CRSP) Insider Trading History

CRISPR Therapeutics (NASDAQ:CRSP) Insider Trade Frequently Asked Questions

Who is on CRISPR Therapeutics's Insider Roster?

What percentage of CRISPR Therapeutics stock is owned by insiders?

Which CRISPR Therapeutics insiders have been selling company stock?

How much insider selling is happening at CRISPR Therapeutics?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

CRISPR Therapeutics Insider Trades

CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling Activity

CurrentInsider OwnershipPercentage10.70%

Number OfInsiders Buying(Last 12 Months)0

Number OfInsiders Selling(Last 12 Months)8

Amount OfInsider Selling(Last 12 Months)$90.89 M

Insider Buying and Selling by Quarter

CRISPR Therapeutics (NASDAQ CRSP) Insider Trading History

CRISPR Therapeutics (NASDAQ:CRSP) Insider Trade Frequently Asked Questions

Who is on CRISPR Therapeutics's Insider Roster?

What percentage of CRISPR Therapeutics stock is owned by insiders?

Which CRISPR Therapeutics insiders have been selling company stock?

How much insider selling is happening at CRISPR Therapeutics?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Current
Insider Ownership
Percentage
10.70%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
8

Amount Of
Insider Selling
(Last 12 Months)
$90.89 M